Clinical Trial

Hybrid Ablation of Atrial Fibrillation in Heart Failure

Study acronym: HALT AF
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 28, 2025 (before its estimated May 2026 completion). Its status may not reflect the trial's current state.
Summary
A randomised controlled trial to assess the efficacy of staged hybrid ablation when compared with standard catheter ablation in patients with non-paroxysmal atrial fibrillation (AF) and Heart Failure
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2022-06-06; most recent amendment 2025-11-23.
Trial Details
NCT Number NCT05411614
Lead Sponsor St. George's Hospital, London
Conditions Persistent Atrial Fibrillation, Atrial Fibrillation, Persistent, Atrial Arrhythmia, Atrial Fibrillation, Heart Failure, Left Ventricular (LV) Systolic Dysfunction
Enrollment 120 participants
Start Date 2022-06-25
Primary Completion 2026-05 (estimated)
Study Completion 2027-10 (estimated)
Updated on ClinicalTrials.gov 2025-11-28